Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.00

+8.5%

Dec 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (3607)	4/27/2001 4:52:28 PM
From: Jibacoa	Read Replies (1) of 52153

Some of Biotech double digits movers today: ANIK: Up 18.11% on the news of the FDA approval of STAARVISC the hyaluronic acid-based product that may be used in various ophthalmic surgeries, including cataract removal and intraocular lens implantation. siliconinvestor.com ARDM: Up 16.80% after declaring earnings yesterdays.(50 cents vs. 48 cents prev.,but still one cent less than estimate.<g>)Still speculation about the "inhaled insulin".<g> siliconinvestor.com CYTO: Up 13.37% after earnings release. Larger loss, but 25% increase in sale in spite of less royalty revenue from Quadramet blamed on "weather disruption of supplies".<g> siliconinvestor.com ENZN: Up 13.74%. After the FDA asked Roche for more data on their Pegasys, which will give ENZN & SGP more time for their launch of Peg-Intron. siliconinvestor.com IMNR: Up 26.17% after news yesterday of been awarded US Patent Number 6,221,352 that covers claims relating to the use of antibodies to target specific TCRs to treat RA. Caveat I am long on IMNR.<g> It has already closed the up-gap from April 23, but there is "resistance" at 3 & 3.50 <g> siliconinvestor.com NERX: Up 15.92% Last news was on April 20 when they reported earnings and completion of its purchase from INIS of a radiopharmaceutical manufacturing plant in TX. siliconinvestor.com PGLAF: Up 25% but volume only 9,000. This is a "penny stock" that a few weeks ago announced the Univ.Hospital in Tapei was going to start a Phase Ib on their anti-angoiogenesis product.<g>Institutions reportedly have been buying lately, I haven't as yet.<g> siliconinvestor.com VLGC: Up 10.53%. It will announce earnings on Wednesday May 9 and will be presenting at CIBC World Markets' First Annual Bio-Technology Conference on Thursday, May 3 at the Millennium Broadway-New York Hotel in New York. siliconinvestor.com KDUS: Down 17% on volume of 1,500 shares to $0.83 was the only double digits looser I could see.<g> Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next